Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Carrato A, Benavides M, Massutí B, Ferreiro-Monteagudo R, García Alfonso P, Falcó E, Reboredo M, Cano T, Gallego J, Viéitez JM, Layos L, Salud A, Polo E, Dotor E, Durán-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E, Aranda E. Carrato A, et al. Among authors: garcia alfonso p. BMC Cancer. 2019 Jun 3;19(1):533. doi: 10.1186/s12885-019-5753-7. BMC Cancer. 2019. PMID: 31159765 Free PMC article. Clinical Trial.
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P. Feliu J, et al. Among authors: garcia alfonso p, garcia giron c. Cancer. 1996 Jul 15;78(2):211-6. doi: 10.1002/(SICI)1097-0142(19960715)78:2<211::AID-CNCR4>3.0.CO;2-O. Cancer. 1996. PMID: 8673994 Clinical Trial.
Integration of panitumumab into the treatment of colorectal cancer.
Gravalos C, Cassinello J, García-Alfonso P, Jimeno A. Gravalos C, et al. Among authors: garcia alfonso p. Crit Rev Oncol Hematol. 2010 Apr;74(1):16-26. doi: 10.1016/j.critrevonc.2009.06.005. Epub 2009 Jul 17. Crit Rev Oncol Hematol. 2010. PMID: 19616446 Review.
Adjuvant chemotherapy for stages II, III and IV of colon cancer.
Grávalos C, García-Escobar I, García-Alfonso P, Cassinello J, Malón D, Carrato A. Grávalos C, et al. Among authors: garcia alfonso p, garcia escobar i. Clin Transl Oncol. 2009 Aug;11(8):526-33. doi: 10.1007/s12094-009-0397-8. Clin Transl Oncol. 2009. PMID: 19661027 Review.
Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.
Garcia-Alfonso P, Muñoz-Martin A, Mendez-Ureña M, Quiben-Pereira R, Gonzalez-Flores E, Perez-Manga G. Garcia-Alfonso P, et al. Br J Cancer. 2009 Oct 6;101(7):1039-43. doi: 10.1038/sj.bjc.6605261. Epub 2009 Sep 8. Br J Cancer. 2009. PMID: 19738605 Free PMC article. Clinical Trial.
Treatment recommendations for metastatic colorectal cancer.
Aranda E, Abad A, Carrato A, Cervantes A, García-Foncillas J, García Alfonso P, García Carbonero R, Gómez España A, Tabernero JM, Díaz-Rubio E. Aranda E, et al. Among authors: garcia carbonero r, garcia alfonso p, garcia foncillas j. Clin Transl Oncol. 2011 Mar;13(3):162-78. doi: 10.1007/s12094-011-0636-7. Clin Transl Oncol. 2011. PMID: 21421461 Review.
Differences in the therapeutic approach to colorectal cancer in young and elderly patients.
Serra-Rexach JA, Jimenez AB, García-Alhambra MA, Pla R, Vidán M, Rodríguez P, Ortiz J, García-Alfonso P, Martín M. Serra-Rexach JA, et al. Among authors: garcia alfonso p, garcia alhambra ma. Oncologist. 2012;17(10):1277-85. doi: 10.1634/theoncologist.2012-0060. Epub 2012 Aug 23. Oncologist. 2012. PMID: 22923453 Free PMC article.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
158 results